id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3555-0007,FDA,FDA-2024-E-3555,Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM,Notice,Determinations,2026-02-26T05:00:00Z,2026,2,2026-02-26T05:00:00Z,2026-04-28T03:59:59Z,2026-02-26T20:35:08Z,2026-03855,1,0,09000064b91dec48
FDA-2024-E-3555-0006,FDA,FDA-2024-E-3555,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-12-02T05:00:00Z,2025,12,2025-12-02T05:00:00Z,,2025-12-03T01:36:37Z,,0,0,09000064b90a9910
FDA-2024-E-3555-0005,FDA,FDA-2024-E-3555,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-11-05T05:00:00Z,2025,11,2025-11-05T05:00:00Z,,2025-11-05T22:26:35Z,,0,0,09000064b9069bbc
FDA-2024-E-3555-0004,FDA,FDA-2024-E-3555,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-06-30T04:00:00Z,2025,6,2025-06-30T04:00:00Z,,2025-11-05T17:57:10Z,,0,0,09000064b8e4579e
FDA-2024-E-3555-0001,FDA,FDA-2024-E-3555,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:06:30Z,,0,0,090000648660d25e
FDA-2024-E-3555-0003,FDA,FDA-2024-E-3555,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:08:37Z,,0,0,090000648660d307
FDA-2024-E-3555-0002,FDA,FDA-2024-E-3555,"Patent Extension Application from Knobbe, Martens, Olson & Bear, LLP (on behalf of LimFlow GmbH (""LimFlow""))",Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:08:04Z,,0,0,090000648660d25f